CIR Panel Prioritizes Paraben Review To Signal EU Before It's 'Too Late'
This article was originally published in The Rose Sheet
Executive Summary
At their March 31-April 1 meeting, CIR's experts opted to tentatively prioritize sodium methylparaben for review in 2017, which could allow them to make a statement on paraben safety in general as regulatory movement in the EU continues to put the ingredients' use in jeopardy.
You may also be interested in...
EU’s Addition Of Butylparaben To SVHC List Won’t Impact Cosmetics Use … Or Will It?
Cosmetic uses of substances of very high concern are excluded from authorization requirements under EU REACH when the substance was listed strictly for endocrine-disrupting concerns. However, cosmetic product manufacturers may find the preservative unavailable from suppliers should butylparaben eventually make the European Chemicals Agency’s Authorization List.
Cosmetic Preservatives Crisis Creeping Into CIR Program
If concerns about cosmetic preservatives are unfounded from a scientific standpoint, then the Cosmetic Ingredient Review Expert Panel should be in a position to set the record straight. However, data gaps have the group considering “insufficient data” findings in pending reviews of parabens and polyaminopropyl biguanide.
CIR Panel's Parabens Review Leaning Toward Safe, But 'Insufficient Data' For Now
Cosmetic Ingredient Review’s independent experts will continue to mull new safety information for parabens, as well as input from a P&G expert, but the panel is inclined to determine the preservatives safe as used in an assessment that could differ “significantly” from European conclusions.